Actos Side Effects May Include Increased Risk of Chronic Kidney DiseaseInjury Lawyer NewsActos Side Effects May Include Risk of Chronic Kidney Disease New research suggests that an increased risk of chronic kidney disease may be among the many Actos si…
|
Six-minute walk test could help guide heart failure treatment
Medical Xpress (HealthDay)—Distance achieved in the six-minute walk test may be a practical measure of functional capacity that guides selection of therapy for patients with heart failure, according to research published online April 9 in the Journal of the American … |
|
UPDATE: Boston Scientific Reports FDA Approval for Latest Generation of Defib …
Benzinga Boston Scientific Corporation (NYSE: BSX) has received FDA approval for its latest generation of defibrillators and heart failure devices designed to advance patient care. The newly approved devices include the DYNAGEN™ MINI and INOGEN™ MINI ICDs, … |
Boston Scientific Corp. (BSX) Reports FDA Approval of Latest Heart Failure …StreetInsider.com (subscription)Boston Scientific Corporation (NYSE: BSX) has received FDA approval for its latest generation of defibrillators and heart failure devices desi…
Milford MercuryInquest into death of Haverfordwest businessman Malcolm Green told of delays …Milford MercuryA post mortem examination found Mr Green had an enlarged and damaged heart, and had suffered multiple organ failure. The cause of death was re…
BBC NewsMalcolm Green: Organ failure after cancer op bleedBBC NewsA businessman had little chance of surviving complications following a cancer operation, an inquest has been told. Malcolm Green, 82, began bleeding internally after surgery to remove a …
Brookings InstitutionPayment and Delivery Reform Case Study: Congestive Heart FailureBrookings InstitutionClinicians and hospitals across the nation struggle with providing and paying for optimal care for their congestive health failure (CHF) patients….
|
Payment and Delivery Reform Case Study: Congestive Heart Failure
Health Affairs (blog) Editor’s note: In addition to Darshak Sanghavi (photo and bio above), this post is coauthored by Meaghan George, a project manager at the Engelberg Center for Health Care Reform at the Brookings Institution. The post is adapted from a full-length case … |
REVIVE-IT heart failure study resumes after safety modificationUniversity of Michigan Health System News (press release)ANN ARBOR, Mich. — The University of Michigan Health System, received approval from the Food and Drug Administration (FDA) on March…
UConn Advance (blog)New Approach to Protecting Heart Failure PatientsUConn Advance (blog)Dr. Bruce Liang, director of the Pat and Jim Calhoun Cardiology Center and chief of the division of cardiology, writes in the journal Circulation about a mechanism…